NAD+ Therapy: Complete Guide
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells that plays a critical role in energy metabolism, DNA repair, and cell signaling. NAD+ levels naturally decline with age, and this decline is associated with numerous age-related diseases. NAD+ therapy, delivered via IV infusion or subcutaneous injection, aims to restore youthful NAD+ levels.
Fact-checking at PeptideProbe is editorial, not clinical. Our editors check claims, dosing figures, and trial results against primary sources; they are not licensed clinicians and do not provide medical review. Nothing here is medical advice — talk to a qualified healthcare provider before starting any therapy.
What is NAD+?
What Is NAD+?
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell and is essential for life. It plays a critical role in hundreds of metabolic reactions, including cellular energy production, DNA repair, gene expression regulation, and cellular signaling. NAD+ exists in two forms: NAD+ (oxidized) and NADH (reduced), and the ratio between them is critical for cellular metabolism.
NAD+ levels decline significantly with age — studies suggest a 50% reduction between ages 40 and 60. This decline is associated with many hallmarks of aging, including mitochondrial dysfunction, DNA damage accumulation, and impaired cellular repair mechanisms. The restoration of NAD+ levels has emerged as one of the most promising strategies in longevity and regenerative medicine.
Administration Methods
NAD+ is available through several routes:
- Intravenous (IV) infusion: The most direct method, achieving the highest blood levels. Typically administered in clinical settings over 2–4 hours.
- Subcutaneous injection: Increasingly popular for maintenance dosing; convenient and effective.
- Intramuscular injection: Less common but used by some practitioners.
- Oral precursors: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are oral supplements that boost NAD+ levels indirectly.
- Nasal spray: Emerging route of administration for direct CNS access.
Clinical Applications
- Anti-aging and longevity: Restoring cellular energy and repair capacity
- Neurodegenerative disease: Supporting neuronal health and cognitive function
- Addiction recovery: NAD+ IV therapy has been used in addiction treatment protocols
- Chronic fatigue: Improving mitochondrial function and cellular energy production
- Athletic performance: Enhancing cellular energy metabolism and recovery
How NAD+ Works
Cellular Energy Production
NAD+ is a critical coenzyme in mitochondrial energy production, serving as an electron carrier in the electron transport chain. It participates in:
- Glycolysis: NAD+ accepts electrons during glucose breakdown
- TCA cycle (Krebs cycle): NAD+ is essential for multiple steps of the cycle
- Oxidative phosphorylation: NADH donates electrons to Complex I of the electron transport chain, driving ATP synthesis
Sirtuin Activation
NAD+ is the essential substrate for sirtuins (SIRT1-7), a family of enzymes often called "longevity genes." Sirtuins regulate:
- DNA repair: SIRT1 and SIRT6 are critical for maintaining genomic stability
- Mitochondrial biogenesis: SIRT1 activates PGC-1α, promoting new mitochondria formation
- Inflammation control: Sirtuins regulate NF-κB and other inflammatory pathways
- Epigenetic regulation: Histone deacetylation by sirtuins influences gene expression patterns
- Circadian rhythm: SIRT1 regulates the molecular clock
PARP-Mediated DNA Repair
NAD+ is consumed by PARP enzymes (Poly-ADP-Ribose Polymerases), which are essential for DNA damage detection and repair. As DNA damage accumulates with age, PARP activity increases, further depleting NAD+ levels and creating a vicious cycle of declining repair capacity.
CD38 and NAD+ Consumption
The enzyme CD38, which increases with age and inflammation, is a major NAD+ consumer. CD38 activity is believed to be one of the primary drivers of age-related NAD+ decline, making NAD+ supplementation a strategy to overcome this enzymatic consumption.
Benefits & Uses
Evidence-Based Benefits of NAD+ Therapy
- Cellular energy restoration: By replenishing a critical coenzyme, NAD+ therapy can restore mitochondrial function and cellular energy production. Patients frequently report improved energy levels and reduced fatigue.
- DNA repair enhancement: NAD+ fuels both sirtuin-mediated and PARP-mediated DNA repair pathways. Animal studies show that NAD+ repletion restores DNA repair capacity in aged tissues (Fang et al., Cell Metabolism, 2016).
- Cognitive function support: Preclinical studies demonstrate that NAD+ repletion through NMN supplementation improves cognitive function and reduces neuroinflammation in aging mouse models (Hou et al., Cell Metabolism, 2018).
- Mitochondrial function: NAD+ activates SIRT1/PGC-1α pathway, promoting mitochondrial biogenesis and improving mitochondrial quality control through mitophagy.
- Inflammatory regulation: Sirtuin activation through NAD+ helps regulate inflammatory responses, potentially beneficial for chronic inflammatory conditions.
- Addiction recovery support: NAD+ IV therapy has been used in addiction treatment centers with reported improvements in withdrawal symptoms and cravings, though controlled clinical trials are limited (Mestayer, Brain Research Foundation reports).
- Cardiovascular support: Animal studies show NAD+ repletion improves vascular function, reduces arterial stiffness, and protects against age-related cardiovascular decline (de Picciotto et al., Aging Cell, 2016).
- Metabolic improvement: Studies show NAD+ precursors improve insulin sensitivity and metabolic parameters in animal models and early human trials.
Clinical Evidence & Research
Research Evidence
NAD+ decline with age (Camacho-Pereira et al., Cell Metabolism, 2016): Established that CD38 is a primary driver of age-related NAD+ decline, and that CD38 inhibition restores NAD+ levels and improves metabolic function in aging mice.
DNA repair (Fang et al., Cell Metabolism, 2016): Demonstrated that NAD+ repletion with NMN restored DNA repair capacity in aged mice and improved cellular function, establishing a mechanistic link between NAD+ decline and age-related genomic instability.
Neurocognitive function (Hou et al., Cell Metabolism, 2018): NMN supplementation improved cognitive function, reduced neuroinflammation, and restored synaptic plasticity in aged mouse models, suggesting potential for neurodegenerative disease prevention.
Human NMN trial (Yoshino et al., Science, 2021): Randomized, double-blind, placebo-controlled trial of oral NMN (250 mg/day) in overweight/obese postmenopausal women showed improved muscle insulin sensitivity and insulin signaling after 10 weeks.
Exercise performance (Liao et al., Journal of the International Society of Sports Nutrition, 2021): NMN supplementation improved aerobic capacity in recreational runners during exercise training, with increased oxygen utilization and ventilatory threshold.
Vascular health (de Picciotto et al., Aging Cell, 2016): NMN supplementation reversed age-related vascular dysfunction in mice, improving endothelial function and reducing arterial stiffness.
Side Effects & Safety
Side Effect Profile
NAD+ therapy is generally well-tolerated, though side effects vary by administration route.
IV NAD+ Infusion Side Effects
- Chest tightness or pressure — Common during IV infusion if the rate is too fast. Managed by slowing the infusion rate.
- Nausea and abdominal cramping — Occurs if the infusion rate is too rapid. Resolves with rate reduction.
- Headache — Reported during or shortly after infusion; usually self-limiting.
- Lightheadedness — Transient; may relate to vasodilation effects.
- Muscle cramping — Occasionally reported during IV infusion.
Subcutaneous/Intramuscular Injection Side Effects
- Injection site pain — NAD+ injections can cause a stinging or burning sensation at the injection site. This is the most commonly reported side effect.
- Injection site redness — Mild erythema and swelling; typically resolves within hours.
- Nausea — Less common than with IV but can occur, particularly at higher doses.
General Considerations
- Sleep disruption: If administered late in the day, NAD+ may cause increased energy and difficulty sleeping. Morning or early afternoon dosing is preferred for injections.
- Flushing: Transient warmth or redness, particularly with higher doses.
Most side effects of IV NAD+ are infusion-rate dependent and can be managed by adjusting the infusion speed. Subcutaneous injection avoids most IV-related side effects but may cause local discomfort.
Dosing & Administration
Common Dosing Protocols
IV NAD+ Infusion
- Standard dose: 250–750 mg per infusion (some protocols use up to 1,000 mg)
- Infusion time: 2–4 hours, adjusted based on tolerance
- Frequency: Loading protocol of 2–4 infusions over 1–2 weeks, followed by monthly maintenance infusions
Subcutaneous Injection
- Standard dose: 50–200 mg subcutaneously, 2–5 times weekly
- Maintenance: 50–100 mg 2–3 times weekly after initial loading phase
Oral Precursors (NMN/NR)
- NMN: 250–1,000 mg orally daily
- NR: 250–500 mg orally daily
Timing: Morning dosing is preferred due to NAD+'s energizing effects and its role in circadian rhythm regulation.
Clinical note: Many practitioners start with a series of IV NAD+ infusions for rapid repletion, then transition to subcutaneous injections or oral precursors for maintenance. The combination of injectable NAD+ with oral NMN is a popular maintenance strategy.
Find NAD+ Providers Near You
Browse 26 listed providers offering NAD+ therapy in our directory. Compare clinics by location, telehealth availability and insurance acceptance.
Browse ProvidersNAD+ FAQ
IV NAD+ provides the highest blood levels most quickly, as it bypasses absorption entirely. Subcutaneous injections provide good bioavailability with convenience. Oral precursors (NMN, NR) are converted to NAD+ in the body but have variable bioavailability. Many practitioners use IV for initial loading, then transition to injections or oral supplements for maintenance.
NAD+ must be infused slowly (over 2-4 hours) because rapid infusion can cause uncomfortable side effects including chest tightness, nausea, and abdominal cramping. The slow rate allows the body to process and utilize the NAD+ without triggering these adverse reactions. Faster rates may be tolerated with experience.
Both NMN and NR raise NAD+ levels, but through slightly different pathways. NMN is one step closer to NAD+ in the biosynthetic pathway and has more recent clinical trial data supporting its efficacy. NR has a longer track record with published human studies. Both are considered effective, and some practitioners recommend combining them.
While direct NAD+ level testing is available through specialized labs, it is not yet standardized. Common symptoms of NAD+ decline include chronic fatigue, brain fog, poor recovery from exercise, accelerated aging signs, and increased susceptibility to illness. Age alone is a strong predictor, as NAD+ levels decline approximately 50% between ages 40 and 60.
NAD+ is essential for mitochondrial energy production, and many patients with chronic fatigue report significant improvement with NAD+ therapy. By restoring cellular energy production capacity and supporting mitochondrial function, NAD+ can address one of the fundamental mechanisms of fatigue. However, chronic fatigue often has multiple contributing factors that should be addressed comprehensively.
NAD+ is a naturally occurring coenzyme essential for life, and replenishing declining levels is generally considered safe. Long-term studies with oral precursors (NMN, NR) have not revealed significant safety concerns. However, very long-term data (decades) is not yet available. Regular monitoring and working with a knowledgeable provider is recommended for ongoing therapy.
What NAD+ is used for
Each of these reviews the evidence for that goal, including where it is weaker than the marketing suggests.
Where to get NAD+ with a prescription
NAD+ requires a prescription and medical supervision. Each service below states that a licensed provider reviews your intake and prescribes through a US compounding pharmacy where appropriate. Those are the companies’ own descriptions of how they operate, not findings of ours. Compounded medications are not FDA-approved, and a consultation does not guarantee a prescription.
Some telehealth links below are affiliate links. If you buy through them, we may earn a commission at no extra cost to you. Commission never affects which products or clinics we list, how they are ordered, or what we say about them — see our editorial policy.
Says a board-certified physician reviews each intake and prescribes through a licensed 503A compounding pharmacy where appropriate, and lists a LegitScript certification. Compounded medications are not FDA-approved.
We are not a clinic and do not prescribe. Listing a service here is not a clinical endorsement of it, and you should confirm licensure and pharmacy sourcing yourself before treatment.
Stay Updated
Get notified when new peptide therapy providers join in your area.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.